• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖秋葵纳米颗粒的制备:作为黏膜黏附药物递送系统的优化与评价

Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.

作者信息

Brar Vivekjot, Kaur Gurpreet

机构信息

Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala - 147002, Punjab, India.

出版信息

Pharm Nanotechnol. 2018;6(3):180-191. doi: 10.2174/2211738506666180813122437.

DOI:10.2174/2211738506666180813122437
PMID:30101724
Abstract

OBJECTIVE

To prepare chitosan-okra gum nanoparticles and their evaluation as mucoadhesive drug delivery system for intranasal delivery of esculin.

METHOD

Esculin loaded chitosan-okra gum based nanoparticles were prepared using ionic gelation method. The preparation method was optimized using Box-Behnken experimental design employing okra gum concentration, chitosan concentration, pH and stirring speed as independent variables and particle size, encapsulation efficiency and zeta potential of the formulation were selected as dependent variables. The optimized formulation was characterized using FTIR, SEM and TEM. The nanoparticles were evaluated for their bioadhesive strength and in vitro drug release studies. The optimized intranasal formulation was administered to rats and the pharmacokinetic profile and biodistribution studies were carried out to calculate the targeting efficiency of the formulation in the brain.

RESULTS

The nanoparticles were found to depict particle size in the range of 294.0 to 613.4 nm. The concentration of gums was found to significantly influence the particle size and encapsulation efficiency. The nanoparticles depicted bioadhesive strength of 32±2%. The in vitro drug release studies showed 96.4±4.2% release of esculin from nanoparticles in 4h. The drug targeting of NPs to brain was found to be nearly double that of esculin given as simple solution.

CONCLUSION

The nanoparticles prepared using chitosan-okra gum were found to possess good mucoadhesive strength with and high brain targeting efficiency.

摘要

目的

制备壳聚糖-秋葵胶纳米粒,并评估其作为载有七叶苷的鼻内给药黏膜黏附性给药系统的性能。

方法

采用离子凝胶法制备载有七叶苷的壳聚糖-秋葵胶基纳米粒。以秋葵胶浓度、壳聚糖浓度、pH值和搅拌速度为自变量,粒径、包封率和制剂的zeta电位为因变量,采用Box-Behnken实验设计对制备方法进行优化。用傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)和透射电子显微镜(TEM)对优化后的制剂进行表征。对纳米粒的生物黏附强度和体外药物释放进行研究。将优化后的鼻内制剂给予大鼠,进行药代动力学和生物分布研究,以计算制剂在脑内的靶向效率。

结果

纳米粒的粒径在294.0至613.4nm范围内。发现胶的浓度对粒径和包封率有显著影响。纳米粒的生物黏附强度为32±2%。体外药物释放研究表明,4小时内七叶苷从纳米粒中的释放率为96.4±4.2%。发现纳米粒对脑的药物靶向性几乎是简单溶液形式给予的七叶苷的两倍。

结论

使用壳聚糖-秋葵胶制备的纳米粒具有良好的黏膜黏附强度和较高的脑靶向效率。

相似文献

1
Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.壳聚糖秋葵纳米颗粒的制备:作为黏膜黏附药物递送系统的优化与评价
Pharm Nanotechnol. 2018;6(3):180-191. doi: 10.2174/2211738506666180813122437.
2
Thiolated okra chitosan nanoparticles: preparation and optimisation as intranasal drug delivery agents.巯基化黄秋葵壳聚糖纳米粒的制备及其作为鼻腔给药载体的优化。
J Microencapsul. 2020 Dec;37(8):624-639. doi: 10.1080/02652048.2020.1836057. Epub 2020 Oct 23.
3
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.载利培酮壳聚糖纳米粒的鼻腔给药制剂及生物药剂学评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1342-1350. doi: 10.1080/03639045.2019.1619759. Epub 2019 Jun 3.
4
Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.罗望子胶、壳聚糖和秋葵胶控释结肠靶向直接压片盐酸普萘洛尔基质片的时辰治疗药物递送及体外评价
Int J Biol Macromol. 2015 Aug;79:290-9. doi: 10.1016/j.ijbiomac.2015.03.031. Epub 2015 May 1.
5
"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".Box-Behnken设计在富马酸喹硫平壳聚糖纳米粒优化及开发中的应用——用于经鼻途径脑递送*
Int J Biol Macromol. 2016 Aug;89:206-18. doi: 10.1016/j.ijbiomac.2016.04.076. Epub 2016 Apr 27.
6
Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.载文拉法辛的壳聚糖 NPs 脑靶向给药:药代动力学和药效学评价。
Carbohydr Polym. 2012 Jun 5;89(1):72-9. doi: 10.1016/j.carbpol.2012.02.051. Epub 2012 Feb 28.
7
Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.载有司来吉兰的壳聚糖纳米颗粒在帕金森病治疗中的生物制药潜力
Curr Drug Discov Technol. 2019;16(4):417-425. doi: 10.2174/1570163815666180418144019.
8
Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.用于鼻脑递送的神经活性药物负载壳聚糖纳米颗粒的制备与评价:体外表征及体内行为研究
Curr Drug Deliv. 2019;16(2):123-135. doi: 10.2174/1567201815666181011121750.
9
Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.通过鼻腔途径的基于壳聚糖的安定粘膜黏附型微乳的脑靶向:制剂优化、特性描述、药代动力学和药效学评价。
Drug Dev Ind Pharm. 2019 Jan;45(1):147-158. doi: 10.1080/03639045.2018.1526186. Epub 2018 Oct 24.
10
Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.用于脑靶向的载有罗匹尼罗的粘膜粘附纳米颗粒的鼻内给药设计、表征及评价
Drug Dev Ind Pharm. 2015;41(10):1674-81. doi: 10.3109/03639045.2014.991400. Epub 2014 Dec 11.

引用本文的文献

1
RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery.载甲泼尼龙红细胞搭便车壳聚糖纳米粒用于肺部靶向递药。
J Control Release. 2022 Jan;341:702-715. doi: 10.1016/j.jconrel.2021.12.018. Epub 2021 Dec 18.